2001

Jun 5, 2001
Guidant Receives European Approval to Treat Long Coronary Blockages with Radiotherapy

Approval Will Allow Physicians to Treat a Greater Number of Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 4, 2001
Guidant Corporation to Donate $1 Million in Medical Technology to the Larry King Cardiac Foundation

Donation to help low-income individuals receive life-saving cardiac therapies LOS ANGELES, CA - During the Larry King Cardiac Foundation fundraiser, "An Evening with Larry King and Friends,"...

May 24, 2001
First Patients Treated With Guidant's Drug-Eluting Stent

Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D(tm) Stent Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2001
Guidant Announces CE Mark Approval and First European Implant of Next-Generation Heart Failure Technology

New Device Includes Diagnostic Capabilities for Better Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European CE Mark approval of...

May 22, 2001
Guidant Unveils Latest Coronary Stent Technology in Europe

Company Launches MULTI-LINK PENTA Stent Indianapolis, Ind. and Santa Clara, Calif. - Physicians in Europe are getting a glimpse at the latest coronary stent technology, following the European...

Show 5102550100 per page
Top